{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:17:33Z","timestamp":1792815453148,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jacc.2022.05.046","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T16:14:54Z","timestamp":1660580094000},"page":"832-844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Inflammatory Diseases of the Aorta"],"prefix":"10.1016","volume":"80","author":[{"given":"Daniella","family":"Kadian-Dodov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi A.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3374-616X","authenticated-orcid":false,"given":"Jeffrey W.","family":"Olin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.jacc.2022.05.046_bib1","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jacc.2010.02.015","volume":"55","author":"Hiratzka","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"41","key":"10.1016\/j.jacc.2022.05.046_bib2","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","volume":"35","author":"Erbel","year":"2014","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.jacc.2022.05.046_bib3","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/heartjnl-2018-314499","article-title":"IgG4-aortitis among thoracic aortic aneurysms","volume":"105","author":"Perez-Garcia","year":"2019","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.jacc.2022.05.046_bib4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/PAT.0000000000000096","article-title":"Ascending aortitis: a\u00a0clinicopathological study of 21 cases in a series of 300 aortic repairs","volume":"46","author":"Xu","year":"2014","journal-title":"Pathology"},{"issue":"3","key":"10.1016\/j.jacc.2022.05.046_bib5","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/ar3360","article-title":"Predictors for pathologically confirmed aortitis after resection of the ascending aorta: a 12-year Danish nationwide population-based cross-sectional study","volume":"13","author":"Schmidt","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.jacc.2022.05.046_bib6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.semtcvs.2018.10.022","article-title":"Incidence of aortitis in surgical specimens of the ascending aorta clinical implications at follow-up","volume":"31","author":"De Martino","year":"2019","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"7-8 Pt 2","key":"10.1016\/j.jacc.2022.05.046_bib7","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.lpm.2017.05.034","article-title":"Epidemiology of Takayasu arteritis","volume":"46","author":"Onen","year":"2017","journal-title":"Presse Med"},{"issue":"2","key":"10.1016\/j.jacc.2022.05.046_bib8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/acr.22931","article-title":"Prevalence, incidence, and disease characteristics of Takayasu arteritis by ethnic background: data from a large, population-based cohort resident in Southern Norway","volume":"69","author":"Gudbrandsson","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.jacc.2022.05.046_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/000331979704800501","article-title":"Clinical manifestations of Takayasu arteritis in India and Japan--new classification of\u00a0angiographic findings","volume":"48","author":"Moriwaki","year":"1997","journal-title":"Angiology"},{"issue":"18","key":"10.1016\/j.jacc.2022.05.046_bib10","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/CIRCULATIONAHA.114.012547","article-title":"Current clinical features of new patients with Takayasu arteritis observed from cross-country research in Japan: age and sex specificity","volume":"132","author":"Watanabe","year":"2015","journal-title":"Circulation"},{"issue":"2 Suppl 89","key":"10.1016\/j.jacc.2022.05.046_bib11","article-title":"Gender differences in clinical and angiographic findings of patients with Takayasu arteritis","volume":"33","author":"Lim","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.jacc.2022.05.046_bib12","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.jacc.2022.05.046_bib13","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/annrheumdis-2011-200865","article-title":"Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography","volume":"71","author":"Prieto-Gonzalez","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"3 Suppl 82","key":"10.1016\/j.jacc.2022.05.046_bib14","first-page":"S55","article-title":"Isolated aortitis versus giant cell arteritis: are they really two sides of the same coin?","volume":"32","author":"Talarico","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.jacc.2022.05.046_bib15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.autrev.2016.02.016","article-title":"Comparison of idiopathic (isolated) aortitis and giant cell arteritis-related aortitis. A French retrospective multicenter study of 117 patients","volume":"15","author":"Espitia","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.jacc.2022.05.046_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/CIRCULATIONAHA.120.045957","article-title":"Long-term outcome and prognosis factors of isolated aortitis","volume":"142","author":"Ferfar","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacc.2022.05.046_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/s10165-011-0508-6","article-title":"A\u00a0novel clinical entity, IgG4-related disease (IgG4RD): general concept and details","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.jacc.2022.05.046_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MD.0b013e3182433d77","article-title":"IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry","volume":"91","author":"Ebbo","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.jacc.2022.05.046_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13075-020-02197-w","article-title":"IgG4-related aortitis\/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease","volume":"22","author":"Peng","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.jacc.2022.05.046_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11926-020-00948-x","article-title":"Pathogenesis of giant cell arteritis and Takayasu arteritis-similarities and differences","volume":"22","author":"Watanabe","year":"2020","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"10.1016\/j.jacc.2022.05.046_bib21","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/annrheumdis-2016-210070","article-title":"An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy","volume":"76","author":"Miyabe","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.jacc.2022.05.046_bib22","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/annrheumdis-2012-201836","article-title":"Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis","volume":"72","author":"Espigol-Frigole","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jacc.2022.05.046_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.carpath.2015.05.001","article-title":"Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases","volume":"24","author":"Stone","year":"2015","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jacc.2022.05.046_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","article-title":"IgG4-related disease","volume":"9","author":"Mahajan","year":"2014","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"10.1016\/j.jacc.2022.05.046_bib25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.jacc.2022.05.046_bib26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-120-11-199406010-00004","article-title":"Takayasu arteritis","volume":"120","author":"Kerr","year":"1994","journal-title":"Ann Intern Med"},{"issue":"22","key":"10.1016\/j.jacc.2022.05.046_bib27","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jacc.2022.05.046_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/BOR.0000000000000129","article-title":"Outcome measures for Takayasu's arteritis","volume":"27","author":"Aydin","year":"2015","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.jacc.2022.05.046_bib29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/acr.20043","article-title":"Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor alpha and interleukin-6) in the long-term followup of patients with giant cell arteritis","volume":"62","author":"Garcia-Martinez","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"10.1016\/j.jacc.2022.05.046_bib30","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.jacc.2022.05.046_bib31","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.1780330811","article-title":"The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jacc.2022.05.046_bib32","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jacc.2022.05.046_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jacc.2022.05.046_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jacc.2022.05.046_bib35","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"suppl_2","key":"10.1016\/j.jacc.2022.05.046_bib36","doi-asserted-by":"crossref","first-page":"ii22","DOI":"10.1093\/rheumatology\/kex461","article-title":"Ultrasound in the diagnosis and management of giant cell arteritis","volume":"57","author":"Schmidt","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.jacc.2022.05.046_bib37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/rheumatology\/kez664","article-title":"British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: executive summary","volume":"59","author":"Mackie","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.jacc.2022.05.046_bib38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1148\/radiol.2020202903","article-title":"Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation","volume":"298","author":"Weinreb","year":"2021","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jacc.2022.05.046_bib39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mrm.25665","article-title":"Golden-angle radial MRI with reconstruction of extra motion-state dimensions using compressed sensing","volume":"75","author":"Feng","year":"2016","journal-title":"Magn Reson Med"},{"issue":"21","key":"10.1016\/j.jacc.2022.05.046_bib40","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1161\/01.CIR.101.21.2503","article-title":"In\u00a0vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography","volume":"101","author":"Fayad","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacc.2022.05.046_bib41","first-page":"219","article-title":"Cross-sectional, prospective study of MRI reproducibility in the assessment of plaque burden of the carotid arteries and aorta","volume":"6","author":"El Aidi","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.jacc.2022.05.046_bib42","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s00259-018-3973-8","article-title":"FDG-PET\/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC","volume":"45","author":"Slart","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1058","key":"10.1016\/j.jacc.2022.05.046_bib43","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150892","article-title":"MRI parametric monitoring of biological therapies in primary large vessel vasculitides: a pilot study","volume":"89","author":"Spira","year":"2016","journal-title":"Br J Radiol"},{"issue":"6","key":"10.1016\/j.jacc.2022.05.046_bib44","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/eurheartj\/ehv607","article-title":"Fully integrated whole-body [18F]-fludeoxyglucose positron emission tomography\/magnetic resonance imaging in therapy monitoring of giant cell arteritis","volume":"37","author":"Einspieler","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacc.2022.05.046_bib45","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00259-011-1967-x","article-title":"The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis","volume":"39","author":"Fuchs","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.jacc.2022.05.046_bib46","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1136\/annrheumdis-2013-204572","article-title":"Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study","volume":"73","author":"Prieto-Gonzalez","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.jacc.2022.05.046_bib47","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jacc.2007.05.024","article-title":"18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials","volume":"50","author":"Rudd","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jacc.2022.05.046_bib48","first-page":"924","article-title":"Diagnostic accuracy of 18F-FDG PET or PET\/CT for large vessel vasculitis : a meta-analysis","volume":"75","author":"Lee","year":"2016","journal-title":"Z\u00a0Rheumatol"},{"issue":"12","key":"10.1016\/j.jacc.2022.05.046_bib49","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/art.40855","article-title":"Outcomes among 196 patients with noninfectious proximal aortitis","volume":"71","author":"Clifford","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jacc.2022.05.046_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/687608","article-title":"The role of 18F-FDG PET\/CT in large-vessel vasculitis: appropriateness of current classification criteria?","volume":"2014","author":"Balink","year":"2014","journal-title":"Biomed Res Int"},{"issue":"1014","key":"10.1016\/j.jacc.2022.05.046_bib51","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1259\/bjr\/16422950","article-title":"18F-Fludeoxyglucose PET\/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters","volume":"85","author":"Papathanasiou","year":"2012","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1016\/j.jacc.2022.05.046_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00005792-198503000-00002","article-title":"Takayasu arteritis. A study of 32 North American patients","volume":"64","author":"Hall","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2022.05.046_bib53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/art.41529","article-title":"Cardiovascular and renal morbidity in Takayasu arteritis: a population-based retrospective cohort study from UK","volume":"73","author":"Goel","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.jacc.2022.05.046_bib54","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.mayocp.2013.04.025","article-title":"Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients","volume":"88","author":"Schmidt","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.jacc.2022.05.046_bib55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/rheumatology\/keu329","article-title":"Large-vessel giant cell arteritis: a cohort study","volume":"54","author":"Muratore","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.jacc.2022.05.046_bib56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.md.0000145366.40805.f8","article-title":"Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.jacc.2022.05.046_bib57","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/annrheumdis-2012-202408","article-title":"Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis","volume":"72","author":"Kermani","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jacc.2022.05.046_bib58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13075-017-1432-8","article-title":"Clinical features of IgG4-related periaortitis\/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case-control study","volume":"19","author":"Ozawa","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.jacc.2022.05.046_bib59","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/ar4671","article-title":"Clinical course after corticosteroid therapy in IgG4-related aortitis\/periaortitis and periarteritis: a retrospective multicenter study","volume":"16","author":"Mizushima","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.jacc.2022.05.046_bib60","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41584-020-0370-z","article-title":"Views on glucocorticoid therapy in rheumatology: the age of convergence","volume":"16","author":"Buttgereit","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.jacc.2022.05.046_bib61","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","article-title":"2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.jacc.2022.05.046_bib62","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A\u00a0practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"7","key":"10.1016\/j.jacc.2022.05.046_bib63","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.jacc.2022.05.046_bib64","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","article-title":"Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis","volume":"56","author":"Mahr","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.jacc.2022.05.046_bib65","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jacc.2022.05.046_bib66","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/annrheumdis-2016-209773","article-title":"Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs","volume":"76","author":"Strangfeld","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jacc.2022.05.046_bib67","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13075-017-1316-y","article-title":"TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study","volume":"19","author":"Gudbrandsson","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.jacc.2022.05.046_bib68","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1093\/rheumatology\/kez630","article-title":"Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study","volume":"59","author":"Nakaoka","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.jacc.2022.05.046_bib69","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.111.058032","article-title":"Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience","volume":"125","author":"Saadoun","year":"2012","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.jacc.2022.05.046_bib70","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIR.0b013e31828b82aa","article-title":"Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF\/AHA guideline recommendations): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"Anderson","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacc.2022.05.046_bib71","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejvs.2018.09.020","article-title":"Editor's Choice - European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms","volume":"57","author":"Wanhainen","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"10.1016\/j.jacc.2022.05.046_bib72","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejvs.2018.09.016","volume":"57","author":"Czerny","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"10.1016\/j.jacc.2022.05.046_bib73","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jvs.2018.04.048","article-title":"Long-term results after open repair of inflammatory infrarenal aortic aneurysms","volume":"69","author":"Wieker","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"issue":"14","key":"10.1016\/j.jacc.2022.05.046_bib74","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of atherosclerotic inflammation by (68)Ga-DOTATATE PET compared to [(18)F]FDG PET imaging","volume":"69","author":"Tarkin","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.05.046_bib75","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1136\/heartjnl-2016-309661","article-title":"An unusual finding in a 57-year-old woman with new onset hypertension and a diastolic murmur","volume":"102","author":"Tarkin","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2022.05.046_bib76","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/ATVBAHA.118.310957","article-title":"Advances in therapies and imaging for systemic vasculitis","volume":"39","author":"Farrah","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722053852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722053852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:50:50Z","timestamp":1760017850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109722053852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0735109722053852"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2022.05.046","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory Diseases of the Aorta","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2022.05.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}